Psoriasiform eruption associated with alopecia areata during infliximab therapy.
Nakagomi
D
D
Harada
K
K
Yagasaki
A
A
Kawamura
T
T
Shibagaki
N
N
Shimada
S
S
D000368:Aged; D000506:Alopecia Areata / Q000139:chemically induced*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D016572:Cyclosporine / Q000008:administration & dosage; D003875:Drug Eruptions; D005260:Female; D006801:Humans; D000069285:Infliximab; D011565:Psoriasis / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D016572:Cyclosporine; D000069285:Infliximab